Private practice with Dr Seth Bilazarian

View all posts »

Left ventriculography: Setting the record straight

Apr 11, 2012 03:35 EDT


The recent paper by Dr Ronald Witteles (Stanford University, CA) contains factual inaccuracies relating to left ventriculographies, and is a disservice to medicine.

See also:

Many left ventriculographies are unnecessary

Witteles RM, Knowles JW, Perez M, et al. Use and overuse of left ventriculography. Am Heart J 2012; DOI:10.1016/j.ahj.2011.12.018. Available at: http://www.ahjonline.com.








Your comments
Left ventriculography: Setting the record straight
# 1 of 2
April 11, 2012 09:28 (EDT)
Payam
I completely agree with you Dr. B. It's a pointless and misdirected "study" that was obviously funded by Aetna. But the most embarrassing thing for the Stanford author is that it is just plain factually incorrect. The paper seems so misdirected, that I wonder if insurance companies are just "testing the waters" to see what they can get away with in this time of "inappropriate procedures" in cardiology (which seems to have become the new buzz phrase."
# 2 of 2
April 16, 2012 08:50 (EDT)
Thippeswamy Murthy, MD

Very well said.  This is a most unfortunate paper and should not have been published.  I felt deeply offended by the author's allegation that we cardiologists are doing this as "an add on procedure" "unnecessarily" essentially to pad our wallets.  I feel I was well trained at the University of Michigan and left ventriculography was always done, except when there contraindications or it was crossing the aortic valve was too difficult (severe aortic stenosis).  The assessment of wall motion is used to correlate the angiographic findings.  Even if there has been a recent echocardiogram: 1. wall motion could have changed for a variety of reasons; 2. echocardiography does not "see" the apex of the heart and has known technical issues.  The authors incorrectly suggest that there is a unique danger to preforming ventriculography which is incorrect.  Air embolism is extremely rare and can happen at any time during a coronary angiogram, care must be taken throughout the entire procedure.  When modern imaging chains, the total amount of contrast used can limited to 10 to 20 mL which is not a large amount.

 

I am very, very surprised to see this type of publication coming from Stanford University.  I wonder what the faculty there thinks of this paper.  Perhaps some of them will be willing to post their comments in this forum. 


You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

About Dr Seth Bilazarian
Seth Bilazarian MD has been a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts since 1993. He is board certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine.

Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.

Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
About this blog
My intent is to create a forum for dialogue on issues pertinent to private practice cardiology around topics such as:

  • Integration of new data and guidelines on inpatient and outpatient practice in clinical and interventional cardiology
  • Practice approaches to the extra clinical issues in dealing with managed care insurers
  • Strategies for navigating the restrictions of pharmacy benefits managers (PBMs) on pharmacologic therapies for our patients
  • Experiences with restrictions on testing and imaging
The video blog (VLOG) will provide an opportunity to share broadly different approaches to the common conundrums we face in caring for patients. My hope is that this forum will provide useful data points for practice outside of tertiary and academic centers and a look inside community hospitals and physician?s practice patterns in the office, starting with mine.